BTRX-335140 是一种有效的选择性口服活性 κ 阿片受体 (KOR) 拮抗剂，对 κOR、μOR 和 δOR 具有拮抗活性，IC50 值分别为 0.8、110 和 6500 nM。它可以很好地分布到 CNS 中，在大鼠中具有良好的体外吸收、分布、代谢、排泄和毒性以及体内药代动力学特征。

BTRX-335140 is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively. BTRX-335140 can distribute well into the CNS. ADMET (absorption, distribution, metabolism, excretion, and toxicity) . BTRX-335140 endows with favorable in vitro ADMET and in vivo pharmacokinetic profiles and medication-like duration of action in rats.

2244614-14-8

C25H32FN5O2

453.55

CYM-53093

DMSO:16.67 mg/mL (36.75 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years